Hope for Less Than 50 Cents a Dose: A Revolutionary Model for Developing Low-Cost Vaccines

This fact sheet describes the model employed by the Meningitis Vaccine Project to develop a safe, affordable, and long-lasting vaccine to combat Group A meningococcal epidemics in Africa, as well as the contributions of the key partners who made the development of MenAfriVac™ possible.

Author(s): PATH

Published: 2011